JP Morgan Chase
TNDM icon

JP Morgan Chase’s Tandem Diabetes Care TNDM Stock Holding History

JP Morgan Chase’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-56,700
Closed -$3.6M – 6016
2019
Q1 		$3.6M Sell
56,700
-93,300
-62% -$4.9M ﹤0.01% 2868
2018
Q4 		$5.7M Buy
+150,000
New +$5.3M ﹤0.01% 2465
2018
Q3 		– Sell
-50,000
Closed -$1.1M – 5826
2018
Q2 		$1.1M Buy
+50,000
New +$615K ﹤0.01% 3774

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JP Morgan Chase's TNDM Position: Q2 2026 in Review

JP Morgan Chase reduced its Tandem Diabetes Care (TNDM) stake by 0.04% in Q2 2026, selling an estimated $2.44K and leaving 349,652 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3372.

JP Morgan Chase first reported a position in TNDM in Q4 2013 and has held it in 41 quarters since. The position peaked at $30.8M in Q4 2013. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • JP Morgan Chase held 349,652 shares of Tandem Diabetes Care worth $5.53M as of Q2 2026.
  • JP Morgan Chase sold 140 Tandem Diabetes Care shares in Q2 2026, an estimated $2.44K.
  • Tandem Diabetes Care made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3372 holding.
  • JP Morgan Chase first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 41 quarters since.
  • JP Morgan Chase's Tandem Diabetes Care position peaked at $30.8M in Q4 2013.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.